CADTH recommends medical abortion reimbursement

By prochoice | April 20, 2017 |

Statement of Vicki Saporta, President and CEO of the National Abortion Federation Canada on the Canadian Agency for Drugs and Technologies in Health (CADTH) recommendation on Mifegymiso: We are pleased that CADTH has recommended that mifepristone and misoprostol be reimbursed for medical abortion care. CADTH’s recommendation will help make medical abortion care more widely accessible…

Read More

Health Canada approves medical abortion medication

By prochoice | July 29, 2015 |

FOR IMMEDIATE RELEASE Wednesday, July 29, 2015 CONTACT: Alissa Manzoeillo 202.667.5881, ext 219; 202.595.4395 (after hours/cell) amanzoeillo@prochoice.org   Statement of Vicki Saporta, President and CEO of the National Abortion Federation (NAF) and NAF Canada: The approval of mifepristone is great news for women in Canada. Mifepristone has been safely and effectively used by millions of…

Read More